Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

OBJECTIVES: Posthoc analysis of treatment satisfaction in patients switching to subcutaneous (SC) peginterferon beta-1a in the ALLOW study. PATIENTS AND METHODS: Patients with relapsing multiple sclerosis treated with intramuscular interferon (IFN) beta-1a or SC IFN beta-1a or beta-1b remained on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendin, Barry, Naismith, Robert T, Wray, Sibyl E, Huang, Deren, Dong, Qunming, Livingston, Terrie, Jones, Daniel L, Watson, Crystal, Jhaveri, Mehul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056153/
https://www.ncbi.nlm.nih.gov/pubmed/30050291
http://dx.doi.org/10.2147/PPA.S157317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056153/
https://www.ncbi.nlm.nih.gov/pubmed/30050291
http://dx.doi.org/10.2147/PPA.S157317

Ejemplares similares